Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04378439 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Appalachian Partnership to Reduce Disparities (Aim 2)

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Primary completion date changed from estimate of May 2027 to May 31, 2026
    • Site details revised
    • Eligibility criteria shortened, about 4 words
  2. Primary and study completion pushed from May 2026 to May 2027
    • Site contact updated
    v17
  3. Collaborators expanded, about 6 wordsv16
  4. Re-verified, no change to tracked fieldsv15
  5. Primary and study completion dates: May 2025 to May 2026v14
Show 12 earlier versionsHide 12 earlier versions
  1. 2 versions Re-verified since Mar 27, 2023, no change to tracked fieldsv12-v13
  2. Start date: Apr 7, 2022 to Apr 1, 2022v11
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 2022 to Apr 7, 2022
    • Site details revised
    v10
  4. Start date: Mar 2022 to May 2022v9
  5. Start date: Nov 2021 to Mar 2022v8
  6. Start date: Oct 2021 to Nov 2021v7
  7. Start date: Jul 2021 to Oct 2021v6
  8. Start date: Jun 2021 to Jul 2021v5
  9. Start date: Oct 2020 to Jun 2021v4
  10. Start date: Aug 2020 to Oct 2020v3
  11. Start date: Jun 2020 to Aug 2020v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
By combining two strategies (i.e., peer navigation and mHealth) into a complete, culturally compatible, bilingual intervention to increase the use of needed HIV, STI, and HCV prevention and care services among racially/ethnically diverse GBMSM and transgender women in rural Appalachia. Study Investigators anticipate that participants in the intervention group, relative to counterparts in the delayed-intervention group, will demonstrate increased HIV, STI, and HCV testing.
Trial Details
NCT Number NCT04378439
Lead Sponsor Wake Forest University Health Sciences
Collaborators: National Institute of Nursing Research (NINR)
Conditions
(from sponsor)		 HIV/AIDS, STI, HCV
Related terms Acquired Immunodeficiency Syndrome, Sexually Transmitted Diseases
Enrollment 141 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov